Afficher la notice abrégée

dc.creatorGeitona, M.en
dc.creatorKousoulakou, H.en
dc.creatorOllandezos, M.en
dc.creatorAthanasakis, K.en
dc.creatorKyriopoulos, I.en
dc.creatorPapanicolaou, S.en
dc.date.accessioned2015-11-23T10:27:23Z
dc.date.available2015-11-23T10:27:23Z
dc.date.issued2009
dc.identifier10.1186/1744-859X-8-15
dc.identifier.issn1744859X
dc.identifier.urihttp://hdl.handle.net/11615/27701
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-67650413662&partnerID=40&md5=481f0432ca2a86b2ac134b0eb02a0c95
dc.subjecterratumen
dc.subjecterroren
dc.titleErratum: Costs and effects of paliperidone extended release compared with alternative oral antipsychotic agents in patients with schizophrenia in Greece: A cost effectiveness study (Annals of General Psychiatry)en
dc.typejournalArticleen


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée